SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
IMMX

Immix Biopharma, Inc. (IMMX)

NASDAQ: IMMX · USD
Healthcare · Biotechnology
$6.96-$0.08 (-1.14%)
 
Market cap
$583M
Insider Score
Analyst consensus

IMMX analyst forecast

IMMX analyst consensus

No analyst ratings in the last 3 months.

IMMX 12-month price target

$20.00+187.4% upsideaverage of 1 firm
$20.00High
$20.00Low

Best analysts covering IMMX

No firm covering IMMX has a call old enough to have finished a 1Y holding period yet.

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

IMMX analyst ratings

FirmPrice targetAction
Morgan Stanley—$20.00+143.3%Price target2026-10-20
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.